EAM Investors, LLC - IMMUNOVANT INC ownership

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of IMMUNOVANT INC
ValueSharesWeighting
Q3 2023$3,933,766
+421.1%
102,520
+157.6%
0.76%
+442.1%
Q2 2023$754,930
-49.7%
39,796
+22.5%
0.14%
-43.1%
Q4 2020$1,501,000
+20.6%
32,498
-8.2%
0.25%
-16.6%
Q3 2020$1,245,00035,3930.30%
Other shareholders
IMMUNOVANT INC shareholders Q4 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 4,448,017$17,347,0004.39%
Deep Track Capital, LP 9,455,000$36,875,0002.42%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 233$60,000,0000.63%
Octagon Capital Advisors LP 579,061$2,258,0000.60%
Eventide Asset Management 5,372,512$20,953,0000.45%
WITTENBERG INVESTMENT MANAGEMENT, INC. 174,000$679,0000.29%
Frazier Life Sciences Management, L.P. 585,759$2,284,0000.22%
BCK CAPITAL MANAGEMENT LP 54,293$212,0000.16%
PLATINUM INVESTMENT MANAGEMENT LTD 777,590$3,033,0000.12%
Bridgefront Capital, LLC 15,649$61,0000.07%
View complete list of IMMUNOVANT INC shareholders